Two macrolide antimicrobials approved for marketing.
D017963:Azithromycin; D001424:Bacterial Infections / Q000188:drug therapy; D017291:Clarithromycin; D004917:Erythromycin / Q000031:analogs & derivatives*; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
D004917:Erythromycin; D017963:Azithromycin; D017291:Clarithromycin